Jump to a section
- What is GHK-Cu?
- Why researchers study it
- Benefits discussed in literature
- Uses discussed in research
- Mechanisms discussed in published studies
- Reported study designs and protocol examples
- Protocol table from cited sources
- Limitations and research gaps
- Documentation checklist
- Related research supplies
- More GHK-Cu research
- Sources and references
Disclosure: Peptide Bio Index is affiliated with SourcePoint Research and may earn from qualifying purchases or affiliate links.
This article summarizes published research and reported study designs. It is not medical advice, dosing guidance, or a personal-use recommendation.
Source-limited research note: The reviewed sources were incomplete, ambiguous, or insufficient for a normal article. This page labels missing details rather than guessing.
This article summarizes what the reviewed published sources report about GHK-Cu (glycyl-L-histidyl-L-lysine copper), focusing on definitions, reasons for research interest, benefits and uses described in the literature, proposed mechanisms, and concrete study examples drawn directly from the provided sources.
What is GHK-Cu?
GHK (glycyl-L-histidyl-L-lysine) is a naturally occurring human tripeptide that forms a high-affinity chelate with copper (GHK-Cu); circulating GHK levels have been reported to decline with age (averaging ~200 ng/mL at age 20 and ~80 ng/mL by age 60 in one review). [S2] [S1]
GHK is detectable in human biological fluids (plasma, saliva, urine) and the copper chelate GHK-Cu has been the focus of experimental and preclinical studies. [S8] [S2]
Why researchers study it
Researchers study GHK-Cu because published reviews and experimental studies report multiple regenerative and protective actions—effects on tissue repair, inflammation, oxidative stress, and gene networks that may underpin diverse biological activities. [S1] [S2]
Interest also stems from potential applications across dermatology/cosmetics, pulmonary and musculoskeletal models, and inflammatory disease models, together with mechanistic signals involving gene expression and conserved signaling pathways. [S3] [S4] [S7]
Benefits discussed in literature
Reported biological activities in reviewed articles include stimulation of angiogenesis and nerve outgrowth, increased synthesis of collagen, elastin and glycosaminoglycans, and support of dermal fibroblast function. [S1] [S3]
Preclinical and review literature describe wound healing and tissue repair actions across multiple organs (skin, lung connective tissue, bone, liver, and stomach lining), along with antioxidant and anti-inflammatory effects noted in in vitro and in vivo studies. [S1] [S2]
Specific reported protective effects include modulation of inflammatory mediators, suppression of aging-associated signaling such as NF-κB (as described in reviews), and reported anti-cancer, anti-anxiety, anti-pain, and anti-aggression activities in the literature cited by reviews. [S1]
In experimental models reviewed, GHK-Cu showed benefits in ulcerative colitis (reduced inflammatory cytokines and improved mucosal repair) and in cigarette smoke–induced skeletal muscle dysfunction (improved muscle mass, cross-sectional area, and grip strength in mice; and cellular rescue effects in myotubes). [S7] [S8]
Uses discussed in research
Topical and cosmetic use: GHK, GHK-Cu and palmitoylated derivatives (Pal-GHK) are promoted and used as anti-wrinkle and skin-remodeling ingredients in cosmetic products; reviews note cellular evidence of anti-wrinkle activity but highlight a lack of clinical studies. [S3]
Preclinical therapeutic research: GHK-Cu has been tested in animal disease and injury models including ulcerative colitis (DSS-induced mice), cigarette smoke–induced skeletal muscle dysfunction (mouse model and C2C12 myotubes), and other tissue repair contexts summarized in reviews. [S7] [S8] [S1]
Orthopaedics and sports medicine literature discuss GHK-Cu among peptides with potential regenerative roles (wound healing, angiogenesis, extracellular matrix remodeling) but emphasize the absence of robust clinical data supporting musculoskeletal indications. [S4] [S5] [S6]
Mechanisms discussed in published studies
SIRT1-related pathways: multiple experimental studies implicate activation or upregulation of SIRT1 as a mediator of GHK-Cu effects, with downstream impacts on STAT3 phosphorylation, tight-junction protein expression (ZO-1, Occludin), and suppression of inflammatory signaling in a colitis model. [S7]
SIRT1-dependent muscle protection: in cigarette smoke models, GHK-Cu was reported to bind and activate SIRT1 (reported binding energy in the study), with SIRT1-mediated deacetylation inhibiting FoxO3a activity (reducing proteolysis markers MuRF1 and atrogin-1), deacetylating Nrf2 (promoting antioxidant enzyme generation), and increasing PGC-1α (supporting mitochondrial function). [S8]
Additional mechanisms summarized in reviews include suppression of NF-κB signaling, activation of DNA repair and proteasome pathways, and broad gene-expression effects proposed to explain diverse regenerative and protective actions. [S1]
Chemical/biophysical properties: the peptide has high affinity for copper and forms the GHK-Cu chelate; chemical modifications (e.g., palmitoylation) or metal complexation have been used to alter physicochemical properties and increase skin permeability in formulation studies discussed in reviews. [S2] [S3]
Reported study designs and protocol examples
Below are protocol details taken directly from the reviewed sources; where protocol elements (amount, route, frequency, duration) are not present in the reviewed excerpts, the entry notes that they were not reported. [S7] [S8]
DSS-induced ulcerative colitis (in vivo): BALB/c mice were used with UC induced by 3% DSS for 14 days; the reviewed excerpt reports outcomes after GHK-Cu treatment but does not report the administered amount, route, frequency, or the treatment duration for GHK-Cu in the excerpt. [S7]
In vitro mucosal/co-culture and macrophage models: a lipopolysaccharide (LPS)-stimulated in vitro UC model in mouse peritoneal macrophages and a co-culture of mouse colonic epithelial cells with macrophages were used to examine GHK-Cu effects; specific amounts, routes, frequencies, and durations of exposure are not reported in the reviewed excerpt. [S7]
Cigarette smoke (CS)–induced skeletal muscle dysfunction (in vivo) and C2C12 myotube (in vitro) models: the study reported plasma GHK measurement in human subjects (COPD and healthy controls) and used C2C12 myotubes and a CS-exposed C57BL/6 mouse model; in vivo GHK-Cu treatment doses reported in the excerpt were 0.2 and 2 mg/kg, while route, dosing frequency, and treatment duration are not reported in the reviewed excerpt. [S8]
Human observational measurement: one study reported plasma GHK levels in patients with COPD (n=9) and age-paired healthy subjects (n=11), with mean plasma GHK concentrations reported in the excerpt; additional methodological details (sampling schedule, assay specifics beyond reversed-phase HPLC as cited) are not reported in the reviewed excerpt. [S8]
Protocol table from cited sources
The following table summarizes protocol details reported in cited studies. These details are provided as literature context only and are not recommendations or instructions.
| Source | Study Type | Model / Subject | Amount Reported | Route Reported | Frequency | Duration | Notes |
|---|---|---|---|---|---|---|---|
| [S7] | Journal Article | BALB/c mice (DSS-induced ulcerative colitis model) | not reported in the reviewed source | not reported in the reviewed source | not reported in the reviewed source | DSS-induced UC for 14 days; GHK-Cu treatment duration not reported in the reviewed source | Reported outcomes: alleviated weight loss, improved disease activity index, reduced colonic edema and shortening, attenuated inflammatory damage, increased goblet cells, suppressed TNF-α/IL-6/IL-1β, upregulated ZO-1 and Occludin, upregulated SIRT1 and suppressed p-STAT3, inhibited RORγt. |
| [S7] | Journal Article (in vitro) | Mouse peritoneal macrophages (LPS-stimulated) and co-culture of mouse colonic epithelial cells (MCECs) with macrophages | not reported in the reviewed source | not reported in the reviewed source | not reported in the reviewed source | not reported in the reviewed source | Used to assess effects on epithelial healing, tight-junction proteins, and inflammatory cytokines; STAT3 silencing was used to probe mechanism. |
| [S8] | Journal Article (human observational / in vivo / in vitro) | Human subjects (plasma measurement: COPD n=9, healthy n=11), C2C12 myotubes (in vitro), C57BL/6 mice (cigarette smoke exposure model) | Plasma GHK levels reported: COPD 70.27 ± 38.87 ng/mL; healthy 133.0 ± 54.54 ng/mL. In vivo GHK-Cu treatment doses reported: 0.2 and 2 mg/kg. | not reported in the reviewed source | not reported in the reviewed source | not reported in the reviewed source | Reported outcomes: in vitro rescue of myotube dysfunction (increased myosin heavy chain, reduced MuRF1/atrogin-1, increased mitochondrial content); in vivo reduced CS-induced muscle mass loss, increased muscle cross-sectional area, improved grip strength; mechanisms linked to SIRT1 activation, FoxO3a inhibition, Nrf2 deacetylation, and increased PGC-1α. |
Limitations and research gaps
- Most primary experimental evidence in the reviewed sources is preclinical (cellular and animal models); clinical human data are limited.
- Reviews and primary studies note a relative absence of randomized controlled clinical trials and limited reporting of dosing route, frequency, and treatment duration in the reviewed excerpts.
- Topical formulation, skin permeability, and clinical effectiveness of GHK-Cu and modified derivatives (e.g., Pal-GHK) are described as incompletely characterized in the published literature provided.
Documentation checklist
- Confirm whether a cited study is preclinical (in vitro/animal) or clinical before drawing conclusions about human effects.
- Verify that any paper reports specific dose, route, frequency, and duration if those details are required for interpretation.
- Check sample sizes and study design (e.g., controls, blinding, randomization) when evaluating evidence strength.
- Look for replication of findings across independent studies and for human clinical trials addressing safety and efficacy.
Related research supplies
- Laboratory freezer boxes and inventory labels for sample organization
- Protein-safe storage microtubes and sealed storage racks
- Cold-chain storage documentation labels (for refrigerated/freezer inventory tracking)
- Laboratory-grade surface disinfectant wipes and bench cleaning supplies
Research organization supplies: Common tools used for research documentation workflows may include lab notebooks, label makers, sample storage boxes, inventory stickers, and temperature log sheets.
Paid-link disclosure: Peptide Bio Index may earn a commission from qualifying purchases. As an Amazon Associate I earn from qualifying purchases.
Compact vial organization
Leng Ke 10-Slot Clear Vial Case
A transparent 10-slot organizer sized for compatible 1–3 mL glass vials. Confirm vial dimensions and documented storage requirements before selection.
Electronics and screen care
iCloth 70% IPA Electronics Wipes
Lint-free wipes marketed for compatible screens and electronics, useful in documentation and equipment work areas.
Batch and inventory labeling
Phomemo M110 Label and Barcode Printer
A compact thermal label printer for inventory identifiers, storage-box labels, batch references, and document-folder organization.
Product listings, specifications, and availability can change. Review the current Amazon listing and manufacturer instructions before ordering. These links are for research organization and compatible surface/equipment-cleaning workflows, not personal-use guidance.
Research Supply Note: For research-use-only sourcing, review current SourcePoint Research inventory and batch documentation at SourcePointResearch.com. Peptide Bio Index is affiliated with SourcePoint Research.
Sources and references
- [S1] Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data.. International journal of molecular sciences. 2018. PMID: 29986520. DOI: 10.3390/ijms19071987
- [S2] Dou Y, Lee A, Zhu L, Morton J, Ladiges W. The potential of GHK as an anti-aging peptide.. Aging pathobiology and therapeutics. 2020. PMID: 35083444. DOI: 10.31491/apt.2020.03.014
- [S3] Mortazavi SM, Mohammadi Vadoud SA, Moghimi HR. Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective.. BioImpacts : BI. 2025. PMID: 39963574. DOI: 10.34172/bi.30071
- [S4] Rahman OF, Lee SJ, Seeds WA. Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.. Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews. 2026. PMID: 41490200. DOI: 10.5435/JAAOSGlobal-D-25-00236
- [S5] Mayfield CK, Bolia IK, Feingold CL, Lin EH, Liu JN, Rick Hatch GF. Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians.. The American journal of sports medicine. 2026. PMID: 41476424. DOI: 10.1177/03635465251357593
- [S6] Mendias CL, Awan TM. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.. Sports medicine (Auckland, N.Z.). 2026. PMID: 41966639. DOI: 10.1007/s40279-026-02437-0
- [S7] Mao S, Huang J, Li J, Sun F, Zhang Q, Cheng Q. Exploring the beneficial effects of GHK-Cu on an experimental model of colitis and the underlying mechanisms.. Frontiers in pharmacology. 2025. PMID: 40672369. DOI: 10.3389/fphar.2025.1551843
- [S8] Deng M, Zhang Q, Yan L, Bian Y, Li R, Gao J. Glycyl-l-histidyl-l-lysine-Cu2+ rescues cigarette smoking-induced skeletal muscle dysfunction via a sirtuin 1-dependent pathway.. Journal of cachexia, sarcopenia and muscle. 2023. PMID: 36905132. DOI: 10.1002/jcsm.13213
Peptide Bio Index is affiliated with SourcePoint Research. Articles may link to SourcePointResearch.com and third-party affiliate products. As an Amazon Associate, Peptide Bio Index earns from qualifying purchases. Content is educational and research-literature focused only and is not medical advice, dosing guidance, or a personal-use recommendation.